Found: 3
Select item for more details and to access through your institution.
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1734, doi. 10.3390/cancers14071734
- By:
- Publication type:
- Article
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP).
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 1, p. 83, doi. 10.1007/s40487-022-00212-5
- By:
- Publication type:
- Article
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. N.PAG, doi. 10.1186/s40164-020-00177-z
- By:
- Publication type:
- Article